These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

216 related items for PubMed ID: 8125753

  • 1. Cytokines in vitreous humor: interleukin-6 is elevated in proliferative vitreoretinopathy.
    Kauffmann DJ, van Meurs JC, Mertens DA, Peperkamp E, Master C, Gerritsen ME.
    Invest Ophthalmol Vis Sci; 1994 Mar; 35(3):900-6. PubMed ID: 8125753
    [Abstract] [Full Text] [Related]

  • 2. Cytokines in proliferative vitreoretinopathy.
    Limb GA, Little BC, Meager A, Ogilvie JA, Wolstencroft RA, Franks WA, Chignell AH, Dumonde DC.
    Eye (Lond); 1991 Mar; 5 ( Pt 6)():686-93. PubMed ID: 1800167
    [Abstract] [Full Text] [Related]

  • 3. Vitreous vascular endothelial growth factor concentrations in proliferative diabetic retinopathy versus proliferative vitreoretinopathy.
    Citirik M, Kabatas EU, Batman C, Akin KO, Kabatas N.
    Ophthalmic Res; 2012 Mar; 47(1):7-12. PubMed ID: 21691136
    [Abstract] [Full Text] [Related]

  • 4. Expression of vitreous cytokines in proliferative vitreoretinopathy: a prospective study.
    Kon CH, Occleston NL, Aylward GW, Khaw PT.
    Invest Ophthalmol Vis Sci; 1999 Mar; 40(3):705-12. PubMed ID: 10067974
    [Abstract] [Full Text] [Related]

  • 5. Chemokines in proliferative diabetic retinopathy and proliferative vitreoretinopathy.
    Abu El-Asrar AM, Struyf S, Kangave D, Geboes K, Van Damme J.
    Eur Cytokine Netw; 2006 Sep; 17(3):155-65. PubMed ID: 17194635
    [Abstract] [Full Text] [Related]

  • 6. Upregulation of RAGE and its ligands in proliferative retinal disease.
    Pachydaki SI, Tari SR, Lee SE, Ma W, Tseng JJ, Sosunov AA, Cataldergirmen G, Scarmeas N, Caspersen C, Chang S, Schiff WM, Schmidt AM, Barile GR.
    Exp Eye Res; 2006 May; 82(5):807-15. PubMed ID: 16364297
    [Abstract] [Full Text] [Related]

  • 7. Intercellular adhesion molecule-1 levels in plasma and vitreous from patients with vitreoretinal disorders.
    Esser P, Bresgen M, Fischbach R, Heimann K, Wiedemann P.
    Ger J Ophthalmol; 1995 Sep; 4(5):269-74. PubMed ID: 7496336
    [Abstract] [Full Text] [Related]

  • 8. Determination of vitreous interleukin-1 (IL-1) and tumour necrosis factor (TNF) levels in proliferative diabetic retinopathy.
    Demircan N, Safran BG, Soylu M, Ozcan AA, Sizmaz S.
    Eye (Lond); 2006 Dec; 20(12):1366-9. PubMed ID: 16284605
    [Abstract] [Full Text] [Related]

  • 9. Soluble TNF receptors in vitreoretinal proliferative disease.
    Limb GA, Hollifield RD, Webster L, Charteris DG, Chignell AH.
    Invest Ophthalmol Vis Sci; 2001 Jun; 42(7):1586-91. PubMed ID: 11381065
    [Abstract] [Full Text] [Related]

  • 10. [A preliminary study on cytokines in proliferative vitreoretinopathy].
    Li X, Huang J.
    Zhonghua Yan Ke Za Zhi; 1998 Jul; 34(4):256-9, 18. PubMed ID: 11877201
    [Abstract] [Full Text] [Related]

  • 11. [Contribution of selected cellular adhesion molecules and proinflammatory cytokines in the pathogenesis of proliferative diabetic retinopathy].
    Adamiec J, Oficjalska-Młyńczak J.
    Przegl Lek; 2007 Jul; 64(6):389-92. PubMed ID: 18159844
    [Abstract] [Full Text] [Related]

  • 12. Interleukin-8, monocyte chemoattractant protein-1 and IL-10 in the vitreous fluid of patients with proliferative diabetic retinopathy.
    Hernández C, Segura RM, Fonollosa A, Carrasco E, Francisco G, Simó R.
    Diabet Med; 2005 Jun; 22(6):719-22. PubMed ID: 15910622
    [Abstract] [Full Text] [Related]

  • 13. Roles of endothelin-1 and selected proinflammatory cytokines in the pathogenesis of proliferative diabetic retinopathy: Analysis of vitreous samples.
    Adamiec-Mroczek J, Oficjalska-Młyńczak J, Misiuk-Hojło M.
    Cytokine; 2010 Mar; 49(3):269-74. PubMed ID: 20015663
    [Abstract] [Full Text] [Related]

  • 14. Vitreous levels of interleukin-6 and vascular endothelial growth factor in macular edema with central retinal vein occlusion.
    Noma H, Funatsu H, Mimura T, Harino S, Hori S.
    Ophthalmology; 2009 Jan; 116(1):87-93. PubMed ID: 19118700
    [Abstract] [Full Text] [Related]

  • 15. Proinflammatory cytokines and angiogenic and anti-angiogenic factors in vitreous of patients with proliferative diabetic retinopathy and eales' disease.
    Murugeswari P, Shukla D, Rajendran A, Kim R, Namperumalsamy P, Muthukkaruppan V.
    Retina; 2008 Jun; 28(6):817-24. PubMed ID: 18536597
    [Abstract] [Full Text] [Related]

  • 16. Pathogenesis of macular edema with branch retinal vein occlusion and intraocular levels of vascular endothelial growth factor and interleukin-6.
    Noma H, Funatsu H, Yamasaki M, Tsukamoto H, Mimura T, Sone T, Jian K, Sakamoto I, Nakano K, Yamashita H, Minamoto A, Mishima HK.
    Am J Ophthalmol; 2005 Aug; 140(2):256-61. PubMed ID: 16086947
    [Abstract] [Full Text] [Related]

  • 17. Concentration of haemodynamic and inflammatory related cytokines in diabetic retinopathy.
    Patel JI, Saleh GM, Hykin PG, Gregor ZJ, Cree IA.
    Eye (Lond); 2008 Feb; 22(2):223-8. PubMed ID: 17001327
    [Abstract] [Full Text] [Related]

  • 18. Risk evaluation of outcome of vitreous surgery based on vitreous levels of cytokines.
    Funatsu H, Yamashita H, Mimura T, Noma H, Nakamura S, Hori S.
    Eye (Lond); 2007 Mar; 21(3):377-82. PubMed ID: 16410812
    [Abstract] [Full Text] [Related]

  • 19. Vitreous leptin levels in retinal disease.
    Maberley D, Cui JZ, Matsubara JA.
    Eye (Lond); 2006 Jul; 20(7):801-4. PubMed ID: 16052255
    [Abstract] [Full Text] [Related]

  • 20. Persistent secretion of vascular endothelial growth factor into the vitreous cavity in proliferative diabetic retinopathy after vitrectomy.
    Itakura H, Kishi S, Kotajima N, Murakami M.
    Ophthalmology; 2004 Oct; 111(10):1880-4. PubMed ID: 15465550
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.